As of Sep 23
| +0.25 / +10.20%|
The 8 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +159.26% increase from the last price of 2.70.
The current consensus among 8 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.